Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Statement of Cash Flows [Abstract]
Net loss	$ (5,848)	$ (19,565)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	4,585	4,191
Bad debt expense and other reserves	217	96
Stock-based compensation	2,632	4,708
Increase in the fair value of contingent consideration liability	92	591
Amortization of lease right-of-use assets	591	909
Impairment of right-of-use assets	0	351
Other noncash expense	383	194
Changes in operating assets and liabilities:
Accounts receivable	2,941	(430)
Prepaid expenses and other assets	1,101	1,364
Accounts payable	2,309	560
Accrued employee expenses	(3,483)	(2,749)
Operating lease liabilities	(877)	(1,209)
Accrued expenses and other current liabilities	(2,594)	(1,160)
Other liabilities	0	48
Net cash provided by (used in) operating activities	2,049	(12,101)
Cash flows from investing activities
Purchase of property and equipment	(2,560)	(3,855)
Net cash used in investing activities	(2,560)	(3,855)
Cash flows from financing activities
Payment for Contingent Consideration Liability, Financing Activities	(1,610)	(1,908)
Proceeds from exercise of common stock options	0	64
Taxes paid related to net share settlement of equity awards	(1,156)	(1,070)
Net cash used in financing activities	(2,766)	(2,914)
Net decrease in cash, cash equivalents and restricted cash	(3,277)	(18,870)
Cash, cash equivalents and restricted cash at beginning of period	133,687	156,648
Cash, cash equivalents and restricted cash at end of period	136,964	175,518
Supplemental disclosures of non-cash activities
Stock-based compensation capitalized for software development	190	222
Capitalized assets included in accounts payable, accrued employee expenses and other accrued expenses	$ 374	$ 708